View Profile

Peter W. Kalivas

Speaking/Presenting-Abstract/Poster at Mtg
Topic Authors / presenters Event name Event date
1. 13th International Conference on In Vivo Methods, Brussels, Belgium September, 2010
2. Psychiatry 60th Anniversary Celebration, Univ Maryland, Baltimore, MD September, 2010
3. Translational Research in Methamphetamine Addiction Conference, Pray, MT July, 2010
4. American Psychiatric Association, New Orleans May, 2010
5. The Salk Institute for Biological Studies, La Jolla, CA March, 2010
6. Marsh Endowed Lectureship in Substance Abuse, Amarillo, Tx March, 2010
7. UCLA Addictions Consortium, Los Angeles, CA February, 2010
8. American College of Neuropsychopharmacology, Ft Lauderdale, FL December, 2009
9. NAMI South Carolina Fall Conference, No Charleston, SC November, 2009
10. Psychiatry Grand Rounds, Vanderbilt University, Nashville, TN November, 2009
11. Staging Neuropsychiatric Disorders, Fundacion Cerebro y Mente, Mojacar, Spain October, 2009
12. Polish Academy of Sciences, Krakow, Poland August, 2009
13. International Neurochemistry Society, Seoul, Korea August, 2009
14. Emotions and the Brain, Berlin, Germany August, 2009
15. International Cannabinoid Society, Chicago, IL July, 2009
16. Learning, reward and addiction, Jerusalem, Israel June, 2009
17. Translational Neuroscience Seminar Series, Department of Neuroscience, Mt Sinai Medical Center May, 2009
18. Pharmacology Seminar, University of Pennsylvania, Philadelphia, PA April, 2009
19. Workgroup on Neuroplasticity, NIDA/NIMH, Washington DC April, 2009
20. Neuroscience Seminar, University of Colorado, Boulder, CO March, 2009
21. NIAAA Seminar Series, Bethesda, MD February, 2009
22. Creighton University School of Medicine Distinguished Lecture Series, Omaha, NB February, 2009
23. Neurobiology of Learning and Memory Colloquium, Department of Neurobiology and Behavior, UC Irvine, CA October, 2008
24. Retirement for Prof James Smith, Wake Forest University, Winston-Salem, NC September, 2008
25. 6th International Meeting on Metabotropic Glutamate Receptors, Taormina, Sicily September, 2008
26. International Narcotics Research Conference, Charleston SC July, 2008
27. Foundation Ipsen 2008 Neuronal Plasticity Prize, Award symposium at Federation of European Neuroscience Society, Geneva July, 2008
28. Solvay Pharmaceuticals, Utrecht, Netherlands June, 2008
29. 7th Dutch Endo-Neuro-Psycho Conference, Amsterdam June, 2008
30. Department of Psychology, University of Gottenberg, Gottenberg, Sweden May, 2008
31. Janssen Psychiatry Faculty Development Program, Orlando, FL May, 2008
32. Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden May, 2008
33. Am Society Pharmacology Experimental Therapeutics, San Diego, CA April, 2008
34. Neuroscience Seminar Series, University of British Columbia, Vancouver, BC March, 2008
35. Brains and Behavior Distinguished Lecture Series, Georgia State University, Atlanta, GA January, 2008
36. Lieber Center for Schizophrenia Seminar, Columbia University, New York, NY January, 2008
37. Molecular Pathology Seminar, Department of Pathology, Johns Hopkins University, Baltimore, MD January, 2008
38. American College of Neuropsychopharmacology, Boca Raton, FL December, 2007
39. Fundacion Cerebro y Mente, Mazagon, Spain October, 2007
40. European Behavioral Pharmacology Society, Tubingen, Germany September, 2007
41. Chile Neuroscience Society, Santiago, Chile September, 2007
42. Department of Pharmacology, University of Colorado Medical School, Denver, CO September, 2007
43. Catecholamine Gordon Conference, Oxford, UK August, 2007
44. Molecular Biology of Addiction, Cold Spring Harbor, NY August, 2007
45. Addiction Symposium, Bar-Ilan, Israel June, 2007
46. Janssen Psychiatry Faculty Development Program, Atlanta, GA May, 2007
47. Pfizer Lecture, American Psychiatric Association, San Diego May, 2007
48. Department of Psychology, Johns Hopkins University, Baltimore April, 2007
49. Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA March, 2007
50. Distinguished Lecture, Department of Ciencias Quimicas, Universidad Nacional de Cordoba, Cordoba, Argentina March, 2007
51. Learning and Memory in Addiction, NIDA, Rockville, MD March, 2007
52. Plenary Lecture, IX Taller, La Falda, Argentina March, 2007
53. Keystone Conference on Neurobiology of Addiction, Santa Fe, NM February, 2007
54. Department of Neuroscience, University of Maryland, Baltimore, MD February, 2007
55. Department of Neurobiology, University of Pittsburgh, Pittsburgh, PA January, 2007
56. Department of Pharmacology, University of Puerto Rico, San Juan, PR January, 2007
57. NIMH Conference on motivational circuits, Bethesda, DC November, 2006
58. NARSAD symposium, New York, NY October, 2006
59. Society for Neuroscience, Atlanta, GA October, 2006
60. Department Pharmaceutical Sciences, University of Montana, Missoula, MT September, 2006
61. Tourette’s Symposium, NINDS, Washington, DC September, 2006
62. Department of Psychology, Clemson University, Clemson, SC September, 2006
63. Psychiatry Faculty Development Program, Miami, FL May, 2006
64. 2006 Rushton Symposium, Florida State University, Talahassee March, 2006
65. 8th Conference on Learning and Memory, UC Irvine, Irvine March, 2006
66. 8th International Neuroscience Winter Conference, Solden, Austria March, 2006
67. Neuroscience Seminar Series, University of Minnesota March, 2006
68. Neurosciences Seminar, Vanderbilt University, Nashville, TN February, 2006
69. Ramon y Cajal Lecture, Instituto Ramon y Cajal, Madrid Spain February, 2006
70. American College of Neuropsychopharmacology, Kona, HI December, 2005
71. Neurosciences Seminar, University of No Carolina, Chapel Hill November, 2005
72. The Gallo Research Institute, University of California, San Francisco October, 2005
73. International Meeting on Implications of Comorbidity for Etiology and Treatment of Neuropsychiatric Disorders, Mazagon, Spain October, 2005
74. 5th International Meeting on Metabotropic Glutamate Receptors, Taormina, Sicily-Italy September, 2005
75. European Behavioral Pharmacology Society, Barcelona, Spain September, 2005
76. NIDA Course, Cold Spring Harbor, NY August, 2005
77. Gene Logic Inc, Cambridge, MA June, 2005
78. Research Society for Alcoholism, Santa Barbara, CA June, 2005
79. Psychiatry Faculty Development Program, W Palm Beach, FL April, 2005
80. Society of Neurosciences in Africa, Capetown, South Africa April, 2005
81. Sigma Xi Banquet Speaker, Citadel College, Charleston, SC April, 2005
82. Department of Pharmacology, University of Washington, Seattle, WA April, 2005
83. National Institute of Drug Abuse, Baltimore, MD March, 2005
84. Department of Psychiatry, Emory University, Atlanta, GA February, 2005
85. Winter Conference on Brain Research, Breckenridge, CO January, 2005
86. Guilford Pharmaceuticals, Baltimore, MD January, 2005
87. American College of Neuropsychopharmacology, San Juan, PR December, 2004
88. Association for Research in Nervous and Mental Disease, New York, NY December, 2004
89. Neuroscience Seminar Series, Southwestern University, Dallas, TX November, 2004
90. University of Cincinnati Medical School 25th Annual Research Forum November, 2004
91. Glutamate in Addiction, NIDA-sponsored Mini-symposium, Society for Neuroscience, San Diego, CA October, 2004
92. Psychiatry Grand Rounds, Yale University Medical School, New Haven, CT October, 2004
93. Psychiatry Grand Rounds, New York Psychiatric Institute/Columbia University, New York, NY September, 2004
94. AAAP/NIDA Conference, Bethesda, MD September, 2004
95. Department of Pharmacology, Nanjing Medical Center, Nanjing, PRC July, 2004
96. Department of Pharmacology and Neuroscience Program, Medical College of Georgia, Augusta, GA June, 2004
97. Fundacion Cerebro y Mente, Madrid, Spain June, 2004
98. Neuroscience Colloquium, University of Chicago, Chicago, IL May, 2004
99. NIDA Symposium, American Psychiatry Association, New York, NY May, 2004
100. Psychiatry Faculty Development Program, W Palm Beach, FL April, 2004
101. Gill Neurobiology Symposium, University of Indiana, Boomington, IN April, 2004
102. Emory Neuroscience Symposium, Emory University, Atlanta, GA April, 2004
103. Children’s Research Institute, Yale University Medical School, New Haven, CT March, 2004
104. Neuroscience Seminar, Yale University Medical School, New Haven, CT March, 2004
105. BRIN Lecture, Erskine College, Due West, SC March, 2004
106. Hunter College, New York, NY March, 2004
107. BRIN Lecture, Columbia University, Columbia, SC February, 2004
108. Neuroscience Seminar, Johns Hopkins University Medical School, Baltimore, MD January, 2004
109. Australian Neuroscience Society, Melbourne, Victoria, Australia January, 2004
110. Cuba-USA Workshop on Biological Psychiatry, Havana, Cuba January, 2004
111. Mahoney Neuroscience Institute, University of Pennsylvania School of Medicine, Philadelphia, PA December, 2003
112. Division of Neuropharmacology, Scripps Research Institute, La Jolla, CA November, 2003
113. Jansen Pharmaceuticals, Beerse, Belgium August, 2003
114. Department Pharmaceutical Sciences, Universidad San Pablo, Madrid, Spain August, 2003
115. Genes and Environment Interplay in Neuropsychiatric Disorders, Mojacar, Spain August, 2003
116. In vivo monitoring of Molecules, Stockholm, Sweden June, 2003
117. Merck Pharmaceuticals, La Jolla, CA May, 2003
118. Psychiatry Faculty Development Program, W Palm Beach, FL May, 2003
119. Grass Lecture, Wayne State University, Detroit, MI May, 2003
120. SEDAPA, Seattle, WA May, 2003
121. Western Washington University, Bellingham, WA May, 2003
122. Glutamate Disorders of Cognition and Motivation, New York Academy of Sciences, New Haven CT April, 2003
123. Department of Psychobiology, UC Irvine, Irvine CA March, 2003
124. Department of VCAPP, Washington State University, Pullman WA March, 2003
125. Program for Neuroscience, Washington State University, Pullman WA March, 2003
126. Department of Neuroscience, Finch Health Science Center, Chicago Medical School, Chicago, IL February, 2003
127. Neuroscience Grand Rounds, Medical University of So Carolina, Charleston, SC January, 2003
128. Winter Conference on Brain Research, Snowbird, UT January, 2003
129. American College of Neuropsychopharmacology, San Juan, PR December, 2002
130. Neurobiology of Relapse: Frontiers and Opportunities National Institute of Drug Abuse, Orlando, FL November, 2002
131. Department of Pharmacology, University of Colorado Medical School, Denver, CO October, 2002
132. Society for Neuroimmunology, Tampa, FL October, 2002
133. Department of Pharmacology, LSU Medical Center, New Orleans, LA October, 2002
134. Neuroscience Center, Tulane University, New Orleans, LA October, 2002
135. Second Conference on the Neuroscience of Drug Addiction, Instituto Superiore di Sanita, Rome, Italy September, 2002
136. American Psychological Association, Chicago, IL August, 2002
137. 33rd International Narcotics Research Conference, Pacific Grove, CA July, 2002
138. Dopamine 2002 Satellite to IUPHAR, Portland, OR July, 2002
139. Department of Biochemistry, Universidad Central del Caribe, Bayamon, PR June, 2002
140. CPDD 24th Annual Meeting, Quebec City, Que, Canada June, 2002
141. McLean Hospital, Harvard University, Cambridge, MA May, 2002
142. Mind-Body and Development, Sonoma, AZ April, 2002
143. Lapse or Relapse National Institute of Drug Abuse, Rockville, MD February, 2002
144. Department of Psychology, Furman University, Furman, SC February, 2002
145. Society for Neuroscience Hellenic Society, San Diego, CA November, 2001
146. American Society of Addiction Medicine, Washington DC November, 2001
147. Neuroscience Special Lecture, Neuroscience Program, Purdue University, W Lafayette, IN October, 2001
148. Department of Pharmacology, Military Medical Institute, Bejing, China October, 2001
149. Department of Pharmacology, Nanjing Medical Center, Nanjing, China October, 2001
150. MUSC Health Connection, Charleston, SC September, 2001
151. International Amino Acids Conference, Vienna, Austria August, 2001
152. Catecholamines Gordon Conference, New Hampshire July, 2001
153. In vivo monitoring of molecules Dublin Ireland June, 2001
154. Retirement Symposium for Professor Akira Horita, University of Washington, Seattle, WA June, 2001
155. NIAAA Gene Therapy Conference, Chapel Hill, NC May, 2001
156. Gallo Center, University of California at San Francisco April, 2001
157. Psychiatry Faculty Development Program, Orlando, FL April, 2001
158. International Catecholamine Conference, Kyoto, Japan April, 2001
159. Grass Lecture Department of Psychology, University of Kentucky, Lexington, KY March, 2001
160. Stimulant-induced Psychosis, Tohoku University, Sendai, Japan March, 2001
161. Department of Neuroscience, University of Pittsburgh, PA March, 2001
162. College of Psychiatric and Neurologic Pharmacists, San Antonio, TX March, 2001
163. Addiction Research Center, Baltimore, MD February, 2001
164. Department of Pharmacology, University of Texas, San Antonio, TX January, 2001
165. Neuropsychiatric Advances in Drug Abuse, Madrid, Spain January, 2001
166. Cross-sensitization NIDA Satellite, Society for Neuroscience, New Orleans, LA November, 2000
167. Frontiers in Neuroscience Colloquium, University of South Carolina, Columbia, SC October, 2000
168. Honorary Symposium for Dr. Scott Mackler, University of Pennsylvania, Philadelphia, PA October, 2000
169. Grand Rounds Department of Psychiatry, University of Miami, Miami, FL September, 2000
170. Cell Biology of Addiction, NIDA, Bethesda, MD July, 2000
171. College for Problems on Drug Dependence, San Juan, PR June, 2000
172. Neural Substrates of Schizophrenia and Drug-induced Psychosis, Madrid, Spain June, 2000
173. Impact of Childhood Intervention on Drug Abuse, NIDA & NIMH, Washington DC May, 2000
174. Department of Physiology, Northwestern University, Chicago, IL May, 2000
175. Department of Psychiatry, University of Maryland, Baltimore, MD May, 2000
176. Cellular basis of drug-induced neuroadaptation NIDA Study Group, Bethesda, MD April, 2000
177. Grass Lecture Vanderbilt University School of Medicine, Nashville, TN April, 2000
178. Department of Pharmacology, University of Georgia, Athens, GA April, 2000
179. Psychiatry Faculty Development Program, Scottsdale, AZ March, 2000
180. Grand Rounds Department of Psychiatry, University of North Carolina, Chapel Hill, NC February, 2000
181. Plenary Lecture American Neuropsychiatric Society, Fort Myers, FL February, 2000
182. Frontiers of Addiction Research, Rome, Italy February, 2000
183. Methamphetamine Study Group, NIDA, Baltimore, MD January, 2000
184. Memory and Neural Plasticity, Park City, UT January, 2000
185. American College of Neuropsychopharmacology, Acapulco, Mexico December, 1999
186. Attention Deficit Hyperactivity Disorder Study Group, NIMH, Bethesda, MD December, 1999
187. Alcohol Center, Wake Forest University, Winston-Salem, NC September, 1999
188. Behavioral Pharmacology Society, Boston, MA September, 1999
189. 6th International Congress on Amino Acids, Bonn, GDR August, 1999
190. Gruenenthal GmbH, Aachen, GDR August, 1999
191. Department of Physiology, Universidad de los Andes, Merida, Venezuela May, 1999
192. Psychiatry Faculty Development Program, Palm Beach, FL April, 1999
193. Grass Lecture University of Mississippi School of Medicine, Jackson, MI April, 1999
194. Cocaine Addiction Research Program, Allelix Neuroscience Inc, Cranbury, NJ March, 1999
195. Department of Pharmacology, Boston University, Boston, MA March, 1999
196. Neuroscience Seminar Series, University of Cincinnati, Cincinnati, OH February, 1999
197. Department of Pharmacology and Physiology, University of South Carolina, Columbia, SC January, 1999
198. Department of Pharmacology, Louisiana State University, Shreveport, LA January, 1999
199. Areces International Symposium of Glutamate and Interaction of Neurotransmitters November, 1998
200. NIH Consensus Development Conference on the Diagnosis and Treatment of ADHD November, 1998
201. Learning and Memory Neuroscience Lecture Series Rockefeller University, New York, NY November, 1998
202. Advancing from the Ventral Striatum to the Extended Amygdala New York Academy of Sciences, Charlottesville, VA October, 1998
203. Elliot Stellar Lecture University of Pennsylvania, Philadelphia, PA September, 1998
204. Grand Rounds Department of Psychiatry, Emory University, Atlanta, GA May, 1998
205. Distinguished Lecturer Program Albany Medical College, Albany, NY May, 1998
206. Department Cell Biology, University of Minnesota April, 1998
207. Lion's Club, Pullman, WA February, 1998
208. Memory and Neural Plasticity Park City, UT January, 1998
209. Idaho Veterinary Medical Association, Post Falls, ID November, 1997
210. Cocaine and a Changing Brain National Institute of Drug Abuse Satellite Symposium, Society for Neuroscience, New Orleans, LA October, 1997
211. American Society for Addiction Medicine, Washington D.C October, 1997
212. Interactive Monoaminergic Basis of Brain Disorders, Mojacar, Southern Adalusia, Spain October, 1997
213. The Role of Neural and Behavioral Plasticity in Chronic Drug Abuse FASEB Summer Research Conference, Copper Mountain, CO August, 1997
214. Department of Pharmacology, University of Washington, Seattle, WA May, 1997
215. Department of Pharmacology and Physiology, Bowman Grey Medical Center, Winston-Salem, NC April, 1997
216. Department of Cell Biology, Duke University Medical Center, Durham, NC April, 1997
217. Child Study Center, Yale University College of Medicine, New Haven, CT April, 1997
218. Department of Pharmacology, University of Arizona Medical Center, Tuscon, AZ January, 1997
219. Vollum Institute, Oregon Health Sciences University, Portland, OR November, 1996
220. Grass Traveling Scientist, Indianapolis Chapter, Indianapolis, IN November, 1996
221. British Association for Psychopharmacology, The Psychopharmacology of Compulsive Drug Use, London, United Kingdom October, 1996
222. Department of Neurobiology and Anatomy, University of Rochester, Rochester, NY October, 1996
223. Plenary Lecture 7th In Vivo Monitoring of Molecules in Neuroscience, Tenerife, Spain September, 1996
224. XX CINP Conference, Melbourne, Victoria, Australia June, 1996
225. Grand Rounds Department of Psychiatry, University of Adelaide, Queen Elizabeth Hospital, SA, Australia June, 1996
226. Center for Neuroscience, The Flinders University Medical Center, Bedford Park, SA February, 1996
227. Non-LTP Plasticity: Circuits and Transmitter Mechanisms, Galveston, TX November, 1995
228. Dopamine Disease States, Mojacar, Southern Adalusia, Spain October, 1995
229. ACNP Panelist, European College of Neuropsychopharmacology, Venice, Italy October, 1995
230. International Workshop on Excitatory Amino Acids, Marseille, France September, 1995
231. 4th International Congress on Amino Acids, Vienna, Austria August, 1995
232. Plenary Lecture, Dopamine Symposium, Taipei, Taiwan July, 1995
233. Gordon Conference on Catecholamines, Lucca, Italy May, 1995
234. Parke-Davis, Ann Arbor, MI January, 1995
235. Department of Pharmacology, University of Michigan, Ann Arbor, MI January, 1995
236. Neuroscience Program, University of Pennsylvania, Philadelphia, PA October, 1994
237. 1st World Congress on Stress, Bethesda, MD October, 1994
238. NIAAA Workshop: Stress, Gender and Alcohol, Bethesda, MD September, 1994
239. 6th Intl Conference on in vivo Methods, Seignosse, France September, 1994
240. 5th Intl Meeting of EBPS, Berlin, Germany September, 1994
241. XIX CINP Congress, Washington DC June, 1994
242. Department of Pharmacology, University of No. Texas, Health Sciences Ctr, Fort Worth, TX June, 1994
243. Department of Cell Biology, Texas Tech, Lubbock, TX February, 1994
244. Department of Pharmacology and Physiology, Medical College of Virginia, Richmond, VA December, 1993
245. department of Anatomy, E. Carolina University, Greenville, NC November, 1993
246. Department of Pharmacology, Emory University, Atlanta, GA November, 1993
247. Tolerance and Sensitization, Pistola, Italy September, 1993
248. Summer Neuropeptide Conference, Martha's Vineyard, MA June, 1993
249. Committee for Problems on Drug Dependence, Toronto, Quebec, Canada June, 1993
250. Department of Pharmacology, University of Wisconsin, Milwaukee, WI April, 1993
251. Department of Chemistry, Idaho State University, Pocatello, ID April, 1993
252. Department of Pharmacology and Physiology, Medical School of St. Louis, St. Louis, MO March, 1993
253. Neurobiology Program, Texas A & M, College Station, TX November, 1992
254. Department of Psychology, Ohio State University, Columbus, OH November, 1992
255. Department of Pharmacology, University of Utah, Salt Lake City, UT November, 1992
256. Eighteenth CINP Congress, Nice, France June, 1992
257. Seventh International Catecholamine Symposium, Amsterdam, The Netherlands June, 1992
258. International Meeting of Strategies for Studying CNS Active Compounds, Valencia, Spain April, 1992
259. Department of Pharmacology, LSU Medical Center, New Orleans, LA April, 1992
260. Psychobiology Program, University of California at Irvine January, 1992
261. Albert Einstein School of Medicine, 8th Annual Einstein Symposium on Psychiatry, New York, NY November, 1991
262. New York State Psychiatric Institute, New York, NY November, 1991
263. International Brain Research Org., Sensitization to Drugs, Montreal, Canada August, 1991
264. Second International Conference on Neurotensin, Miami, FL July, 1991
265. Department of Pharmacology, University of Chicago, Chicago, IL March, 1991
266. Department of Psychiatry, Wayne State University School of Medicine, Detroit, MI March, 1991
267. Department of Pharmacology, University of Colorado Medical Center, Denver, CO March, 1991
268. Department of Pharmacology, University of Texas Medical School, Galveston, TX February, 1991
269. Nucleus Accumbens: An Opening Blossom Satellite Symposium of 1990 Society for Neuroscience October, 1990
270. Satellite Symposium of CINP, Vulnerability to Schizophrenia, Sendai, Japan September, 1990
271. The Addiction Research Center, Baltimore, MD June, 1990
272. Division of Preclinical Neuroscience, Scripps Clinic and Research Foundation, La Jolla, CA April, 1990
273. Department of Pharmacology, V.E.R. des Sciences Pharmaceutiques et Biologies, Paris, France March, 1990
274. Winter European Brain Conference, Bourg St. Maurice, France February, 1990
275. Department of Pharmacology, Duke University School of Medicine January, 1990
276. Burroughs Wellcome Co., Research Triangle Park, N.C January, 1990
277. American College of Neuropsychopharmacology, Maui, HI December, 1989
278. Department of Psychiatry, Yale University School of Medicine, New Haven, CT October, 1989
279. Department of Anatomy, Wright State University, Dayton, OH May, 1989
280. Alcoholism and Drug Abuse Institute, University of Washington, Seattle, WA April, 1989
281. Department of Pharmacology, Loyola University, Chicago, IL March, 1989
282. Department of Psychiatry, University of Pennsylvania, Philadelphia, PA December, 1988
283. Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada November, 1988
284. Department of Pharmacology, McGill University, Montreal, QUE, Canada October, 1988
285. Department of Psychology, Concordia University, Montreal, QUE, Canada October, 1988
286. Department of Pharmacology, Oregon Health Sciences University, Portland, OR April, 1988
287. American College of Neuropsychopharmacology, San Juan, Puerto Rico December, 1987
288. Department of Psychiatry, Louisiana State University Medical Center, Shreveport, LA December, 1987
289. Department of Psychiatry, Stanford University Medical School, Palo Alto, CA June, 1987
290. XVII International Society of Psychoneuroendocrinology, Chapel Hill-Durham, NC June, 1987
291. Department of Pharmacology, Columbia University, New York, NY May, 1987
292. New York Academy of Sciences, Miami, FL May, 1987
293. School of Pharmacy, Oregon State University, Corvallis, OR April, 1987
294. Department of Neurobiology, University of Florida, Gainsville, FL March, 1987
295. American College of Neuropsychopharmacology, Washington, D.C. December, 1986
296. Grand Rounds, New York State Psychiatric Institute, Columbia University, New York, NY October, 1986
297. XX International Congress of Physiological Sciences, Vancouver, B.C. July, 1986
298. Department of Pharmacology, University of Pennsylvania, Philadelphia, PA May, 1986
299. Neuroscience Research Branch, McNeil Pharmaceuticals, Spring House, PA May, 1986
300. Schizophrenia Support Group, Pullman, WA February, 1986
301. Experimental Station, DuPont, Wilmington, DE October, 1985
302. Lewiston Mental Health Center, Lewiston, ID October, 1985
303. Department of Psychiatry, Duke University Medical Center, Durham, NC September, 1985
304. IVth World Congress of Biological Psychiatry, Philadelphia September, 1985
305. Department of Pharmacology, North Carolina State University, Raleigh, NC September, 1985
306. American College of Neuropsychopharmacology, San Juan, Puerto Rico December, 1984
307. Department of Pharmacology, Yale School of Medicine, New Haven, CT September, 1984
308. Central Research Department, DuPont Glenolden Lab, Glenolden, PA July, 1984
309. Department of Psychiatry, University of California at San Diego Medical School, La Jolla May, 1984
310. First International Symposium on Endocoids, Fort Worth, Texas May, 1984
311. Unit on Behavioral Neuropharmacology, National Institute of Mental Health, Bethesda, MD April, 1984
312. American College of Neuropsychopharmacology, San Juan, Puerto Rico December, 1983
313. Groupe NB, INSERM, College de France, Paris, France November, 1982
314. Universite de Bordeaux II, Laboratorie de Neurobiologie dex Comportements, Bordeaux, France November, 1982
315. Department of Psychology, University of Georgia, Athens June, 1982
316. Environmental Protection Agency, Research Triangle Park, NC April, 1982
317. N.Y. Academy of Sciences, New York March, 1982
318. Department of Psychiatry, University of Pennsylvania, Philadelphia March, 1982
319. Division of Psychiatry, Clinical Research Centre, Harrow, London, England September, 1981
320. TRH Satellite Symposium, International Society for Neurochemistry, Nottingham, U.K September, 1981


Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation Event Month, Year
The glutamate homeotasis hypothesis of addiction Aquitaine Conferences on Neurosciences October, 2010

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.